Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study

References

• Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007;261(6):529–542. doi:10.1111/j.1365-2796.2007.01783.x
   PubMed Web of Science ®Google Scholar
• Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol. 2012;4(2):18–34. doi:10.4254/wjh.v4.i2.18
   PubMedGoogle Scholar
• Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998;115(4):937–946. doi:10.1016/S0016-5085(98)70266-5
   PubMed Web of Science ®Google Scholar
• Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39(2):157–169. doi:10.1016/j.gtc.2010.02.003
   PubMed Web of Science ®Google Scholar
• Zamani F, Sohrabi MR, Motamed N, et al. Prevalence and risk factors of cholelithiasis in Amol city, Northern Iran: a population based study. Arch Iran Med. 2014;17(11):750–754.
   PubMedGoogle Scholar
• Toosi FS, Ehsanbakhsh AR, Tavakoli MR. Asymptomatic gallstones and related risk factors in Iran. Hepatogastroenterology. 2010;58(109):1123–1126.
   Google Scholar
• Massarrat S. Prevalence of gallstone disease in Iran. J Gastroenterol Hepatol. 2001;16(5):564–567. doi:10.1046/j.1440-1746.2001.02478.x
   PubMedGoogle Scholar
• Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11(11):1653–1657. doi:10.3748/wjg.v11.i11.1653
   PubMedGoogle Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. doi:10.2337/diab.37.12.1595
   PubMed Web of Science ®Google Scholar
• Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12(2):125–130. doi:10.1111/j.1751-2980.2011.00487.x
   PubMedGoogle Scholar
• Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923. doi:10.1053/jhep.2003.50161
   PubMed Web of Science ®Google Scholar
• Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29(1):109–117. doi:10.1385/ENDO:29:1:109
   PubMed Web of Science ®Google Scholar
• Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28(4):339–350. doi:10.1055/s-0028-1091978
   PubMed Web of Science ®Google Scholar
• Milic S, Stimac D. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis. 2012;30(2):158–162. doi:10.1159/000336669
   PubMed Web of Science ®Google Scholar
• Koch LK, Yeh MM. Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging. Ann Diagn Pathol. 2018;37:83–90. doi:10.1016/j.anndiagpath.2018.09.009
   PubMedGoogle Scholar
• Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–81 e4. doi:10.1053/j.gastro.2018.12.036
   PubMed Web of Science ®Google Scholar
• Jaruvongvanich V, Sanguankeo A, Upala S. Significant association between gallstone disease and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Dig Dis Sci. 2016;61(8):2389–2396. doi:10.1007/s10620-016-4125-2
   PubMed Web of Science ®Google Scholar
• Shen SS, Gong JJ, Wang XW, et al. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: a systematic review and meta-analysis. Turk J Gastroenterol. 2017;28(1):31–39. doi:10.5152/tjg.2016.0357
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
   PubMed Web of Science ®Google Scholar
• Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III update: adjustments and options. Am J Cardiol. 2005;96(4):53E–9E. doi:10.1016/j.amjcard.2005.06.006
   PubMedGoogle Scholar
• Azizi F, Hadaegh F, Khalili D, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426–428.
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745–750. doi:10.1053/gast.2002.35354
   PubMed Web of Science ®Google Scholar
• Kim SS, Lee JG, Kim DW, et al. Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women. Korean J Intern Med. 2011;26(3):285–293. doi:10.3904/kjim.2011.26.3.285
   PubMedGoogle Scholar
• Tung TH, Ho HM, Shin HC, et al. A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. World J Gastroenterol. 2006;12(28):4536–4540. doi:10.3748/wjg.v12.i28.4536
   PubMedGoogle Scholar
• Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80(1):1–2. doi:10.1093/ajcn/80.1.1
   PubMed Web of Science ®Google Scholar
• Kern Jr F, Erfling W, Braverman D. Why more women than men have cholesterol gallstones: studies of biliary lipids in pregnancy. Trans Am Clin Climatol Assoc. 1979;90:71–75.
   PubMedGoogle Scholar
• Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7(2):132–140. doi:10.1007/s11894-005-0051-8
   PubMedGoogle Scholar
• Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci. 2008;23(4):644–650. doi:10.3346/jkms.2008.23.4.644
   PubMed Web of Science ®Google Scholar
• Ata N, Kucukazman M, Yavuz B, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25(5):274–276. doi:10.1155/2011/356761
   PubMedGoogle Scholar
• Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB. 2007;9(2):92–97. doi:10.1080/13651820701286177
   PubMedGoogle Scholar
• Ilychenko AA. Gallstone disease. Lechashchiy Vrach. 2004;4:27–33.
   Google Scholar
• Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012;18(31):4215–4220. doi:10.3748/wjg.v18.i31.4215
   PubMedGoogle Scholar
• Lonardo A, Lombardini S, Scaglioni F, et al. Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol. 2006;12(36):5826–5833. doi:10.3748/wjg.v12.i36.5826
   PubMedGoogle Scholar
• Fracanzani AL, Valenti L, Russello M, et al. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One. 2012;7(7):e41183. doi:10.1371/journal.pone.0041183
   PubMed Web of Science ®Google Scholar
• Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012;47(2):197–203. doi:10.3109/00365521.2011.643481
   PubMed Web of Science ®Google Scholar
• Liu J, Lin H, Zhang C, et al. Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population. BMC Gastroenterol. 2014;14(1):213. doi:10.1186/s12876-014-0213-y
   PubMedGoogle Scholar
• Qiao QH, Zhu WH, Yu YX, Huang FF, Chen LY. Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine (Baltimore). 2017;96(38):e7853. doi:10.1097/MD.0000000000007853
   PubMed Web of Science ®Google Scholar
• Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg. 2017;17:7–13. doi:10.1016/j.amsu.2017.03.015
   PubMedGoogle Scholar
• Garcia-Monzon C, Vargas-Castrillon J, Porrero JL, et al. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver Int. 2015;35(8):1983–1991. doi:10.1111/liv.12813
   PubMedGoogle Scholar
• Yilmaz Y, Ayyildiz T, Akin H, et al. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. Gut Liver. 2014;8(3):313–317. doi:10.5009/gnl.2014.8.3.313
   PubMed Web of Science ®Google Scholar
• Kim YK, Kwon OS, Her KH. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: an observational study. Medicine (Baltimore). 2019;98(27):e16018. doi:10.1097/MD.0000000000016018
   PubMed Web of Science ®Google Scholar
• Chang Y, Noh YH, Suh BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: a cohort study. J Clin Med. 2018;7(11):458. doi:10.3390/jcm7110458
   PubMed Web of Science ®Google Scholar
• Lee YC, Wu JS, Yang YC, Chang CS, Lu FH, Chang CJ. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scand J Gastroenterol. 2014;49(8):1001–1006. doi:10.3109/00365521.2014.920912
   PubMed Web of Science ®Google Scholar
• Yue W, Sun X, Du T. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. BMC Endocr Disord. 2019;19(1):95. doi:10.1186/s12902-019-0423-y
   PubMed Web of Science ®Google Scholar
• Kwak MS, Kim D, Chung GE, Kim W, Kim YJ, Yoon JH. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. World J Gastroenterol. 2015;21(20):6287–6295. doi:10.3748/wjg.v21.i20.6287
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol. 2013;108(6):952–958. doi:10.1038/ajg.2013.70
   PubMed Web of Science ®Google Scholar
• Yener O, Aksoy F, Demir M, Ozcelik A, Erengul C. Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. Turk J Gastroenterol. 2010;21(4):411–415. doi:10.4318/tjg.2010.0128
   PubMedGoogle Scholar
• Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol. 2014;20(44):16649–16664. doi:10.3748/wjg.v20.i44.16649
   PubMed Web of Science ®Google Scholar
• Montet JC, Caroli-Bosc FX, Ferrari P, et al. Gallbladder motility and gut hormone plasma levels in subjects with and without gallstones. Gastroenterol Clin Biol. 2005;29(5):569–572. doi:10.1016/S0399-8320(05)82131-1
   PubMedGoogle Scholar
• Ballestri S, Nascimbeni F, Lugari S, Lonardo A, Francica G. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Rev Gastroenterol Hepatol. 2019;13(7):667–681. doi:10.1080/17474124.2019.1621164
   PubMed Web of Science ®Google Scholar